Search results for:
aflibercept ophthalmic
aflibercept ophthalmic
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Aflibercept |
SOLUTION, INTRAVITREAL |
40 mg/mL (2 mg/0.05 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aflibercept HD |
SOLUTION, INTRAVITREAL |
114.3 mg/mL (8 mg/0.07 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Feb. 6, 2025
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of aflibercept intravitreal solution (Eylea HD) is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions